Manufactured by:ProteoGenix
Save 20%RUO

Recombinant Human ASB9 Protein, N-His

Recombinant Human ASB9 Protein, N-His from ProteoGenix; catalogue ARO-P11789; research use only.

SKU:
ABM142226-1
Manufacturer SKU
ARO-P11789
Product type
Recombinant Proteins
Expression systemProkaryotic expression

Manufacturer provenance

Manufactured by:
ProteoGenix
Sold by:
ABMIUM
Fulfilled from:
Manufacturer facility or confirmed fulfilment location

Know who made it. See the evidence. Buy through one marketplace.

Product description

Introduction

Recombinant human ASB9 protein is a synthetic version of the ASB9 protein, which is a member of the ankyrin repeat and SOCS box-containing (ASB) protein family. This protein plays an important role in regulating cellular processes such as protein degradation, cell signaling, and immune response. In this article, we will discuss the structure, activity, and potential applications of recombinant human ASB9 protein.

Structure of Recombinant Human ASB9 Protein

The recombinant human ASB9 protein is a 19 kDa protein consisting of 170 amino acids. It contains an N-terminal ankyrin repeat domain and a C-terminal SOCS box domain. The ankyrin repeat domain is responsible for protein-protein interactions, while the SOCS box domain is involved in targeting proteins for degradation through the ubiquitin-proteasome pathway.

Activity of Recombinant Human ASB9 Protein

The main activity of recombinant human ASB9 protein is its role in protein degradation. It acts as an E3 ubiquitin ligase, which means it helps in the transfer of ubiquitin molecules to target proteins. This tagging of proteins with ubiquitin marks them for degradation by the proteasome. ASB9 has been shown to interact with various proteins involved in different cellular processes, such as cytokine signaling, cell cycle regulation, and immune response.

Moreover, ASB9 has been found to regulate the activity of several important proteins, including p53, c-Jun, and NF-κB. These proteins are involved in cell growth, differentiation, and survival. By targeting these proteins for degradation, ASB9 plays a crucial role in maintaining cellular homeostasis and preventing the development of diseases such as cancer.

Application of Recombinant Human ASB9 Protein

Recombinant human ASB9 protein has potential applications in both research and therapeutic settings. In research, it can be used to study the role of ASB9 in various cellular processes and its interactions with different proteins. It can also be used to investigate the effects of ASB9 dysregulation in diseases such as cancer.

In terms of therapeutics, ASB9 has been identified as a potential target for cancer treatment. Studies have shown that ASB9 is overexpressed in several types of cancer, including breast, lung, and prostate cancer. By targeting ASB9 with specific inhibitors, it may be possible to prevent the degradation of important proteins involved in cancer progression.

Furthermore, ASB9 has also been linked to autoimmune diseases such as rheumatoid arthritis and multiple sclerosis. In these conditions, ASB9 may play a role in regulating the activity of immune cells. By targeting ASB9, it may be possible to modulate the immune response and potentially alleviate symptoms of these diseases.

Conclusion

In summary, recombinant human ASB9 protein is a synthetic version of the ASB9 protein that plays an important role in protein degradation and cellular processes. Its structure, consisting of an ankyrin repeat domain and a SOCS box domain, allows it to interact with and regulate various proteins involved in cell signaling and immune response. With its potential applications in research and therapeutics, recombinant human ASB9 protein holds promise in further understanding the role of ASB9 in diseases and potentially developing targeted treatments.

ProteoGenix catalogue number ARO-P11789. For research use only.

Host: Escherichia coli (E.coli); Expression system: Prokaryotic expression; Molecular weight: 30.30 kDa; Fragment: Ser38-Leu294; Buffer: Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol..

Available configurations: 50ug, 100ug, 1mg.

Download the manufacturer datasheet

Key facts & specifications
Also known as
ASB9, Ankyrin repeat and SOCS box protein 9, ASB-9
Host species
E. coli
Source organism
Human
Molecular weight
30.30 kDa
Sequence fragment
Ser38-Leu294
Sequence
SPMHEAAIHGHQLSLRNLISQGWAVNIITADHVSPLHEACLGGHLSCVKILLKHGAQVNGVTADWHTPLFNACVSGSWDCVNLLLQHGASVQPESDLASPIHEAARRGHVECVNSLIAYGGNIDHKISHLGTPLYLACENQQRACVKKLLESGADVNQGKGQDSPLHAVARTASEELACLLMDFGADTQAKNAEGKRPVELVPPESPLAQLFLEREGPPSLMQLCRLRIRKCFGIQQHHKITKLVLPEDLKQFLLHL
Technical note
For research use only.
Identifiers & database references
Manufacturer SKU
ARO-P11789
UniProt accession
Q96DX5
Storage, stability & shipping
Storage conditions
4°C for short term (1 week), -20°C or -80°C for long term (avoid freezing/thawing cycles; addition of 20-40% glycerol improves cryoprotection)
Shipped at
Dry Ice
Compliance & documents
ISO certifications
ISO 9001:2023, ISO 14001: 2023
Datasheet
Open datasheet
Frequently asked questions
Who manufactured this product?

This product is manufactured by ProteoGenix and sold through ABMIUM without relabelling.

Can ABMIUM ship this product internationally?

ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.

Can I check suitability before ordering?

Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.

Is this product for clinical use?

Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.

ProteoGenix
£169.00£135.20